RxDoctor Payments Data

Oluwatosin Ayotunde, MD

Interventional Pain Medicine · Phoenix, AZNPI 1730718214

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,219 of the $4,613 with a category attached, or 69.8%. 10 manufacturers reported payments, led by Boston Scientific at 28.4% of the total. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.

$4,613in general payments, 2019–2025

Across 39 payments — averaging $118.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Abbott$1K
  • Medtronic$613
  • Nevro Corp.$586
  • Nalu Medical, Inc.$352
  • Bioventus LLC$227
  • plus $520 from 4 others

What the payments were for

  • Travel & lodging$1,39430%
  • Food & beverage$3,21970%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,613 in reported general payments places this provider in the 35th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$28,899
Medicare patients
171
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol23$406
Ondansetron OdtOndansetron12$324
Cephalexin18$164
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$88
Doxycycline Hyclate12$57
Prednisone24$48

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →